Clinical trial teams face a difficult balance: preserve scientific rigor while making protocols feasible for sites and participants. In this sponsored episode of The Top Line, host Kelly Hogan speaks with Metta Anderson, general manager of data analytics and insights at WCG, about how protocol burden affects enrollment timelines and trial performance. Anderson discusses how generative AI and large language models can extract structured information from complex protocol documents, enabling data-driven comparisons with other protocols and standard of care. She shares findings from a WCG study of about 1,000 protocols and enrollment rates across 109,000 sites, including the impact of participant and site burden on enrollment timelines. The conversation also explores why teams should critically evaluate procedures, visits, endpoints and data that may not be essential to the trial’s critical path. Their conversation explores how burden scoring, strong data foundations and subject matter expertise can help teams design more efficient trials, reduce amendment risk and better respect the time of sites and participants.



